Advertisement

PharmacoEconomics & Outcomes News

, Volume 819, Issue 1, pp 22–22 | Cite as

Genomic Prostate Score good value for guiding treatment

Clinical study
  • 3 Downloads

Reference

  1. Chang EM, et al. Cost Effectiveness of the Oncotype DX Genomic Prostate Score for Guiding Treatment Decisions in Patients With Early Stage Prostate Cancer. Urology : 21 Dec 2018. Available from: URL: http://doi.org/10.1016/j.urology.2018.12.016

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations